Ventas owns a diversified healthcare portfolio of almost 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care... Show more
The Moving Average Convergence Divergence (MACD) for VTR turned positive on October 17, 2025. Looking at past instances where VTR's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on October 17, 2025. You may want to consider a long position or call options on VTR as a result. In of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
VTR moved above its 50-day moving average on October 15, 2025 date and that indicates a change from a downward trend to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where VTR advanced for three days, in of 327 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 316 cases where VTR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
VTR broke above its upper Bollinger Band on October 30, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. VTR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating for company is (best 1 - 100 worst), which means the company is slightly undervalued. The valuation of the company is based on a proprietary formula which takes into account a set of fundamentals and gives us an estimate of the price per share for the company. We then compare this estimate with the current price per share. As a result, this company is rated as undervalued in the industry. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.922) is normal, around the industry mean (2.094). P/E Ratio (145.094) is within average values for comparable stocks, (67.164). VTR's Projected Growth (PEG Ratio) (1.717) is slightly lower than the industry average of (3.265). Dividend Yield (0.025) settles around the average of (0.065) among similar stocks. P/S Ratio (6.215) is also within normal values, averaging (6.806).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock better than average.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
a real estate investment trust
Industry ManagedHealthCare
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| PLTZ | 6.23 | 0.42 | +7.23% |
| Defiance Daily Target 2X Short PLTR ETF | |||
| SPHB | 114.02 | 0.77 | +0.68% |
| Invesco S&P 500® High Beta ETF | |||
| SLYV | 90.13 | 0.06 | +0.07% |
| State Street® SPDR® S&P 600™ Sm CpValETF | |||
| DWUS | 54.57 | -0.04 | -0.08% |
| AdvisorShares DW FSM US Core ETF | |||
| MVRL | 14.43 | -0.32 | -2.15% |
| ETRACS Mnthly Py 1.5X Lvgd Mtg REIT ETN | |||
A.I.dvisor indicates that over the last year, VTR has been closely correlated with WELL. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if VTR jumps, then WELL could also see price increases.
| Ticker / NAME | Correlation To VTR | 1D Price Change % | ||
|---|---|---|---|---|
| VTR | 100% | +0.96% | ||
| WELL - VTR | 79% Closely correlated | -0.35% | ||
| NHI - VTR | 69% Closely correlated | -0.74% | ||
| PLD - VTR | 67% Closely correlated | -1.12% | ||
| OHI - VTR | 61% Loosely correlated | -1.02% | ||
| SBRA - VTR | 60% Loosely correlated | -1.46% | ||
More | ||||
| Ticker / NAME | Correlation To VTR | 1D Price Change % |
|---|---|---|
| VTR | 100% | +0.96% |
| VTR (3 stocks) | 89% Closely correlated | +0.40% |
| Managed Health Care (28 stocks) | 82% Closely correlated | +0.12% |
| Health Services (422 stocks) | -7% Poorly correlated | -2.10% |